2010•Cochrane Database of Systematic ReviewsRequires access

Cabergoline for preventing ovarian hyperstimulation syndrome

Huilin Tang, Tamara Hunter, HU Yong-fang, Suo-Di Zhai, Xiaoyan Sheng, Roger J Hart

Open publisher page 9 citations

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of cabergoline in preventing ovarian hyperstimulation syndrome (OHSS) in high‐risk patients undergoing assisted reproduction technology treatment.

About this research paper

What this paper is about

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of cabergoline in preventing ovarian hyperstimulation syndrome (OHSS) in high‐risk patients undergoing assisted reproduction technology treatment.

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the effectiveness and safety of cabergoline in preventing ovarian hyperstimulation syndrome (OHSS) in high‐risk patients undergoing assisted reproduction technology treatment.

Key concepts: Cabergoline, Ovarian hyperstimulation syndrome, Medicine, Gynecology, Internal medicine, Biology, Pregnancy, In vitro fertilisation

Related papers

Back to paper searchBrowse research topicsOriginal source
Cabergoline for preventing ovarian hyperstimulation syndrome — Research Paper | ScholarLens